Impact of Obesity Pharmacotherapies on Behavioral Health

Live Webinar

Pharmacotherapy is an important tool in obesity management. Understanding its effects on behavioral health is essential. This webinar will examine the relationship between obesity medications and mental health outcomes.

Overview

Pharmacotherapy is an important tool in obesity management. Understanding its effects on behavioral health is essential. This webinar will examine the relationship between obesity medications and mental health outcomes.

Learning Objectives

Identify the major classes of pharmacotherapies used in obesity management and their potential effects on behavioral health.
Recognize the mechanisms by which obesity medications may influence mental health outcomes, including both benefits and risks.
Evaluate patient case scenarios to determine appropriate obesity pharmacotherapy options, considering behavioral health factors and evidence-based guidelines.

Speaker

Dr. Janelle Coughlin, PhD
Associate Director, Center for Behavior and Health
Director, Obesity Behavioral Medicine Program Johns Hopkins

Moderator

Jessica Bartfield, MD
Clinical Associate Professor at Wake Forest University School of Medicine

Funder Acknowledgment

Novo Nordisk is a strategic supporter of the Obesity Association, a division of the American Diabetes Association.

Summary

Availability:

Registration Required

Expires on Mar 18, 2027

Location:

Online Meeting

Date / Time:

Mar 18, 2026 4:00 PM - 5:00 PM ET

Cost:

FREE

Credit Offered:

No Credit Offered

Create Account